Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000177299 | SCV000229144 | benign | not specified | 2015-05-01 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000177299 | SCV000240917 | benign | not specified | 2015-02-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
| Center for Pediatric Genomic Medicine, |
RCV000438446 | SCV000510600 | likely benign | not provided | 2016-12-09 | criteria provided, single submitter | clinical testing | Converted during submission from Likely Benign to Likely benign. |
| Labcorp Genetics |
RCV003765095 | SCV000562684 | benign | Absence seizure; Myoclonic epilepsy, juvenile, susceptibility to, 1 | 2025-01-06 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV003927641 | SCV004741474 | benign | EFHC1-related disorder | 2019-10-01 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |